Roche Diagnostics supplies molecular testing instruments to support Ebola response in the DRC
QIAGEN completes US QIAstat-Dx bloodstream infection portfolio with FDA clearance
Armata Pharmaceuticals announces receipt of FDA Breakthrough Therapy Designation for AP-SA02
Immuron signs US distribution deal for PROIBS
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Roche expands cyclospora testing portfolio to support US public health response